Global Brain Disease Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1319

Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer’s, Huntington’s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others.  The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.
The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
In 2018, the global Brain Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Brain Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brain Disease development in United States, Europe and China.

The key players covered in this study
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca

Market segment by Type, the product can be split into
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others

Market segment by Application, split into
Hospitals Pharmacy
Online Pharmacy
Pharmacy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Brain Disease status, future forecast, growth opportunity, key market and key players.
To present the Brain Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Brain Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Brain Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Brain Cancer
1.4.3 Alzheimer Disease
1.4.4 Alcoholism
1.4.5 Amnesia
1.4.6 Epilepsy
1.4.7 Meningitis
1.4.8 Others
1.5 Market by Application
1.5.1 Global Brain Disease Market Share by Application (2014-2025)
1.5.2 Hospitals Pharmacy
1.5.3 Online Pharmacy
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Brain Disease Market Size
2.2 Brain Disease Growth Trends by Regions
2.2.1 Brain Disease Market Size by Regions (2014-2025)
2.2.2 Brain Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Brain Disease Market Size by Manufacturers
3.1.1 Global Brain Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Brain Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
3.2 Brain Disease Key Players Head office and Area Served
3.3 Key Players Brain Disease Product/Solution/Service
3.4 Date of Enter into Brain Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Brain Disease Market Size by Type (2014-2019)
4.2 Global Brain Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Brain Disease Market Size (2014-2019)
5.2 Brain Disease Key Players in United States
5.3 United States Brain Disease Market Size by Type
5.4 United States Brain Disease Market Size by Application

6 Europe
6.1 Europe Brain Disease Market Size (2014-2019)
6.2 Brain Disease Key Players in Europe
6.3 Europe Brain Disease Market Size by Type
6.4 Europe Brain Disease Market Size by Application

7 China
7.1 China Brain Disease Market Size (2014-2019)
7.2 Brain Disease Key Players in China
7.3 China Brain Disease Market Size by Type
7.4 China Brain Disease Market Size by Application

8 Japan
8.1 Japan Brain Disease Market Size (2014-2019)
8.2 Brain Disease Key Players in Japan
8.3 Japan Brain Disease Market Size by Type
8.4 Japan Brain Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Brain Disease Market Size (2014-2019)
9.2 Brain Disease Key Players in Southeast Asia
9.3 Southeast Asia Brain Disease Market Size by Type
9.4 Southeast Asia Brain Disease Market Size by Application

10 India
10.1 India Brain Disease Market Size (2014-2019)
10.2 Brain Disease Key Players in India
10.3 India Brain Disease Market Size by Type
10.4 India Brain Disease Market Size by Application

11 Central & South America
11.1 Central & South America Brain Disease Market Size (2014-2019)
11.2 Brain Disease Key Players in Central & South America
11.3 Central & South America Brain Disease Market Size by Type
11.4 Central & South America Brain Disease Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Brain Disease Introduction
12.1.4 Pfizer Revenue in Brain Disease Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Brain Disease Introduction
12.2.4 Eli Lilly Revenue in Brain Disease Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 F. Hoffmann La Roche
12.3.1 F. Hoffmann La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Brain Disease Introduction
12.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2014-2019)
12.3.5 F. Hoffmann La Roche Recent Development
12.4 GE Healthcare
12.4.1 GE Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Brain Disease Introduction
12.4.4 GE Healthcare Revenue in Brain Disease Business (2014-2019)
12.4.5 GE Healthcare Recent Development
12.5 Janssen Pharmaceuticals
12.5.1 Janssen Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Brain Disease Introduction
12.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2014-2019)
12.5.5 Janssen Pharmaceuticals Recent Development
12.6 Abbvie
12.6.1 Abbvie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Brain Disease Introduction
12.6.4 Abbvie Revenue in Brain Disease Business (2014-2019)
12.6.5 Abbvie Recent Development
12.7 AC Immune
12.7.1 AC Immune Company Details
12.7.2 Company Description and Business Overview
12.7.3 Brain Disease Introduction
12.7.4 AC Immune Revenue in Brain Disease Business (2014-2019)
12.7.5 AC Immune Recent Development
12.8 Allergan
12.8.1 Allergan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Brain Disease Introduction
12.8.4 Allergan Revenue in Brain Disease Business (2014-2019)
12.8.5 Allergan Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Brain Disease Introduction
12.9.4 Merck Revenue in Brain Disease Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Novartis
12.10.1 Novartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Brain Disease Introduction
12.10.4 Novartis Revenue in Brain Disease Business (2014-2019)
12.10.5 Novartis Recent Development
12.11 AstraZeneca

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details